1998
DOI: 10.7164/antibiotics.51.1081
|View full text |Cite
|
Sign up to set email alerts
|

BE-31405, a New Antifungal Antibiotic Produced by Penicillium minioluteum. I. Description of Producing Organism, Fermentation, Isolation, Physico-chemical and Biological Properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(17 citation statements)
references
References 12 publications
0
17
0
Order By: Relevance
“…As far as we are aware this is the first report of P. oxalicum producing an antifungal substance containing least two active compounds. Fungi of the genus Penicillium are important producers of antibacterial compounds, but only a few are reported to produce antifungal substances (Kumagai et al 1990;Matsukuma et al 1992;Jackson et al 1993;Okada et al 1998;Nose et al 2000;Sasaki et al 2000;Kaiserer et al 2003;He et al 2004;Nicoletti et al 2004). HPLC separation results showed that strain PY-1 produced at least two active compounds which may significantly inhibit mycelial growth of many pathogenic fungi and suppress infection by S. sclerotiorum when aerially applied.…”
Section: Discussionmentioning
confidence: 97%
“…As far as we are aware this is the first report of P. oxalicum producing an antifungal substance containing least two active compounds. Fungi of the genus Penicillium are important producers of antibacterial compounds, but only a few are reported to produce antifungal substances (Kumagai et al 1990;Matsukuma et al 1992;Jackson et al 1993;Okada et al 1998;Nose et al 2000;Sasaki et al 2000;Kaiserer et al 2003;He et al 2004;Nicoletti et al 2004). HPLC separation results showed that strain PY-1 produced at least two active compounds which may significantly inhibit mycelial growth of many pathogenic fungi and suppress infection by S. sclerotiorum when aerially applied.…”
Section: Discussionmentioning
confidence: 97%
“…However, signifi cant in vivo activity has not been observed with sordarin because of unfavorable pharmacokinetic characteristics (short half-life and low concentrations) and limited in vitro activity against pathogenic fungi [68]. To overcome these issues, several synthetic sordarin derivatives have been synthesized with modifi cations to the chemical structure that have increased in vitro potency and more favorable pharmacokinetic characteristics in vivo [68][69][70]. One of these is FR290581 (Astellas Pharma, Inc., Osaka, Japan) ( Table 1 and Fig.…”
Section: Mechanism Of Action and In Vitro Activitymentioning
confidence: 98%
“…In the case of ionizable functional groups existing in the solute molecules, solutions of weak acids or bases can be utilized in order to ensure conversion to the ionized species which then allows rapid elution owing to the repulsive interactions with the support. Examples of isolations where synthetic resins have been utilized in the isolation process and the solvents used to effect elution from the resins are shown for BE-31405 ( 27 ) , calphostin D ( 28 ) , tubelactomicin A ( 29 ) , DC-52 and the artifact derived from it DX-52-1 ( 30, 31 ) , teicoplanin A 2 -2 ( 32 ) , and pentostatin ( 33 ) in Table 5 .…”
Section: Liquid Solid Chromatographymentioning
confidence: 99%